News | Information Technology | January 16, 2017

Top 18 Technologies Fueling Growth Opportunities in Global Healthcare

Stakeholders that are not invested in any of these by 2025 will fall behind the curve, finds Frost & Sullivan’s Transformational Health team

Frost & Sullivan, 18 technologies, growth opportunities, global healthcare, information technology, 2025

January 16, 2017 — Frost & Sullivan, released a new report, “Vision 2025 – Future of Healthcare,” part of the company’s Advanced Medical Technologies, that identifies 18 technologies that will impact healthcare paradigms by 2025.

Technology-driven transformation in global healthcare demands that stakeholders identify influential technologies and re-strategize to ride the strongest growth currents. As healthcare moves to the anytime, anyplace, continuous and personalized care model, technological advances are unlocking values and previously inaccessible segments.

“Although these technologies are making waves within research, two aspects must be weighed to assess potential market impact,” noted Frost & Sullivan Transformational Health Research Analyst Siddharth Shah. “The first is the commercialization and maturity timelines for these technologies. The second is aligning the technologies with Healthcare 2025 trends and themes in order to successfully leverage growth opportunities.”

Some technologies set to create billion-dollar opportunities, according to the report, include: wearables, enhanced prosthetics, nanorobotics, electroceuticals, advanced materials, population health analytics, quantum computing, wellness gamification, regenerative medicine and precision medicine.

To be profitable, companies must identify the technologies that will impact their business and invest accordingly, according to Frost & Sullivan. For instance:

  • Artificial intelligence (AI) is set to speed up the analysis of large volumes of data to efficiency levels that exceed human capability;
  • Brain-computer interfaces can connect a “wired” brain directly with an external device for “neural bypass,” which will help paralyzed patients move or blind patients see;
  • Digital avatars offer holographic projections of doctors to answer health queries, similar to voice assistants like Cortana and Siri; and
  • Medical tricorders can record health vitals and parameters to diagnose a range of health conditions without a physician.

Frost & Sullivan’s analysis offers timeframes for commercialization and indicates when significant on-the-ground healthcare impact will be seen for each technology. Some of the frontrunners in the race for enabling healthcare technologies include IBM Watson Health with its AI for healthcare, Organovo for 3-D bioprinting, DeepStream VR for its virtual reality applications, and QualComm with its $10 million tricorderX inducement prize contest to develop medical tricorders.

For more information: www.frost.com

Related Content

Philips Smart diagnostic systems empower patients and staff with more definitive diagnostic and interventional radiology studies, optimized workflows, enhanced efficiency and operational excellence
News | Artificial Intelligence | November 25, 2020
November 25, 2020 — Philips announced its participation in the RSNA...
 Lunit, a leading medical AI software company, will be joining the 106th Radiological Society of North America (RSNA) this year, presenting its AI solutions for chest X-ray and mammography at partner booths.
News | Artificial Intelligence | November 24, 2020
November 24, 2020 — Lunit, a leading medical AI software company, will be joining the 106th...
New multimodality virtual imaging command center enables real-time, remote collaboration to broaden expertise between technologists, radiologists and imaging operations teams across multiple sites via private, secure telepresence capabilities
News | Information Technology | November 24, 2020
November 24, 2020 — Philips announced commercial launch of the industry’s first vendor-neutral, multimodality, radiol
ProFound AI for DBT offers superior clinical performance when compared to other commercially available breast AI systems
News | Breast Imaging | November 24, 2020
November 24, 2020 — iCAD reported that over 1,000 licenses have been sold as part of...
Videos | Enterprise Imaging | November 23, 2020
Fujifilm's next generation secure server-side viewer platform extends across...
Single-slice of the chest CT showing the abnormalities. Arrows indicate the location of the breast mass (red arrow), lymphadenopathy (blue arrow), and a lung nodule (yellow arrow). Arrows not present in experimental display. Image courtesy of Psychonomic Bulletin & Review

Single-slice of the chest CT showing the abnormalities. Arrows indicate the location of the breast mass (red arrow), lymphadenopathy (blue arrow), and a lung nodule (yellow arrow). Arrows not present in experimental display. Image courtesy of Psychonomic Bulletin & Review

Feature | Radiology Imaging | November 20, 2020
There’s a classic video demonstrating how our brains process information and allocate attention in which people bounc
Densitas Inc., a global provider of A.I. technologies for digital mammography and breast screening, announced its partnership with Mammography Educators to offer the first artificial intelligence powered telehealth technologist training platform to support business continuity in mammography facilities.
News | Mammography | November 20, 2020
November 20, 2020 — Densitas Inc., a global provider of A.I.